NOVO NORDISK A/S |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 133.8 EUR | -0.93% |
|
+1.88% | +45.39% |
| 06-28 | India plans incentives for diabetes, obesity drug makers in 2026, government official says | RE |
| 06-28 | NOVO NORDISK : UBS gives a Neutral rating | ZD |
Quotes 5-day view
Delayed Quote Börse Stuttgart| 2024-06-25 | 2024-06-26 | 2024-06-27 | 2024-06-28 | 2024-07-01 | |
|---|---|---|---|---|---|
| Last | 137 € | 135 € | 135 € | 135.5 € | 133.5 € |
| Volume | 266 | 901 | 430 | 1 518 | 0 |
| Change | +3.79% | -1.46% | 0.00% | +0.37% | -0.93% |
| Opening | 133.00 | 139.00 | 134.50 | 135.00 | 133.5 |
| High | 138.00 | 139.50 | 135.00 | 135.50 | 133.5 |
| Low | 132.50 | 134.50 | 133.50 | 133.50 | 133.5 |
Performance
| 1 week | +1.88% | ||
| Current month | +9.27% | ||
| 1 month | +10.61% | ||
| 3 months | +13.39% | ||
| 6 months | +43.84% | ||
| Current year | +45.39% | ||
| 1 year | +89.51% | ||
| 3 years | +289.37% | ||
| 5 years | +507.62% | ||
| 10 years | +726.60% |
Volumes
marketsCapital turnover ratio
0.00
Float rotation
0.00
Basic data
Capitalization (EUR)
4 442 389 537 263
Capitalization (USD)
640 796 921 192
Net sales (DKK)
232 261 000 000
Net sales (USD)
33 502 720 206
Free-Float
70.22 %
Free-Float capitalization (EUR)
3 138 087 655 771
Free-Float capitalization (USD)
452 656 591 994
Average Daily Capital Traded
0%
Highs and lows
1 week
132.00
139.50
1 month
121.00139.50
3 years
34.80139.50
5 years
21.10139.50
10 years
14.80139.50
Indicators
Moving average 5 days
134.90
Moving average 20 days
131.55
Moving average 50 days
124.61
Moving average 100 days
120.78
Price spread / (MMA5)
+0.86%
Price spread / (MMA20)
-1.64%
Price spread / (MMA50)
-6.83%
Price spread / (MMA100)
-9.70%
STIM
RSI 9 days
62.20
RSI 14 days
62.28
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Monthly variations
Annual change
| 2024 | +43.51% | ||
| 2023 | +46.77% | ||
| 2022 | +28.28% | ||
| 2021 | +72.17% | ||
| 2020 | +10.58% | ||
| 2019 | +32.32% | ||
| 2018 | -12.22% | ||
| 2017 | +31.99% | ||
| 2016 | -36.39% | ||
| 2015 | +53.89% | ||
| 2014 | +31.31% | ||
| 2013 | +7.02% |
- Stock Market
- Equities
- NOVO B Stock
- NOVA Stock
- Quotes Novo Nordisk A/S
